Literature DB >> 9557170

Indirect assessment of 4,4'-diphenylmethane diisocyanate (MDI) exposure by evaluation of specific humoral immune responses to MDI conjugated to human serum albumin.

B D Lushniak1, C M Reh, D I Bernstein, J S Gallagher.   

Abstract

BACKGROUND: A study of occupational asthma among workers exposed to 4,4'-Diphenylmethane Diisocyanate (MDI).
OBJECTIVE: To demonstrate if serum concentrations of MDI-specific IgG or IgE are sensitive biological markers of disease or of MDI exposure.
METHODS: The study group consisted of nine MDI-exposed workers and nine nonexposed workers. Air sampling for MDI and polymethylene polyphenyl isocyanate, occupational and medical histories, respiratory physical exams, pre- and postshift spirometry, and self-administered peak expiratory flow rates were performed. Serum specific IgE and IgG antibodies to an MDI-human serum albumin (HSA) conjugate were assayed by the radioallergosorbent test and the enzyme-linked immunosorbent assay, respectively, and compared to nine nonexposed laboratory controls.
RESULTS: No definitive cases of occupational asthma were documented. The mean level of MDI-specific IgG was significantly greater among exposed workers compared to nonexposed workers and laboratory controls (p = 0.04). Mean levels of TDI and HDI-specific IgG were also increased.
CONCLUSION: This study demonstrates that serum concentrations of MDI-specific IgG appear to be a moderately sensitive biological marker of MDI exposure, but not an indicator of occupational asthma. Workers with IgG antibodies specific for one diisocyanate-HSA conjugate exhibit cross-reactivity to antigens prepared with other diisocyanates.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9557170     DOI: 10.1002/(sici)1097-0274(199805)33:5<471::aid-ajim6>3.0.co;2-v

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  9 in total

1.  Upper reference limits for biomarkers of exposure to aromatic diisocyanates.

Authors:  Carl Johan Sennbro; Margareta Littorin; Håkan Tinnerberg; Bo A G Jönsson
Journal:  Int Arch Occup Environ Health       Date:  2005-07-02       Impact factor: 3.015

2.  Biomonitoring Hexamethylene diisocyanate (HDI) exposure based on serum levels of HDI-specific IgG.

Authors:  Adam V Wisnewski; Meredith H Stowe; Abby Nerlinger; Paul Opare-Addo; David Decamp; Christopher R Kleinsmith; Carrie A Redlich
Journal:  Ann Occup Hyg       Date:  2012-03-26

Review 3.  Hazardous air pollutants and asthma.

Authors:  George D Leikauf
Journal:  Environ Health Perspect       Date:  2002-08       Impact factor: 9.031

4.  Is specific IgE antibody analysis feasible for the diagnosis of methylenediphenyl diisocyanate-induced occupational asthma?

Authors:  Lygia Therese Budnik; Alexandra M Preisser; Hjalmar Permentier; Xaver Baur
Journal:  Int Arch Occup Environ Health       Date:  2012-04-28       Impact factor: 3.015

5.  Biomarkers predicting isocyanate-induced asthma.

Authors:  Nami Shrestha Palikhe; Joo-Hee Kim; Hae-Sim Park
Journal:  Allergy Asthma Immunol Res       Date:  2010-07-29       Impact factor: 5.764

6.  Opportunities and obstacles in translating evidence to policy in occupational asthma.

Authors:  Susan M Tarlo; Ahmed A Arif; George L Delclos; Paul Henneberger; Jenil Patel
Journal:  Ann Epidemiol       Date:  2017-03-31       Impact factor: 3.797

7.  Update on the Pathogenic Mechanisms of Isocyanate-induced Asthma.

Authors:  Gyu-Young Hur; Sung-Jin Choi; Seung-Youp Shin; Sang-Ha Kim; Hae-Sim Park
Journal:  World Allergy Organ J       Date:  2008-01       Impact factor: 4.084

8.  Antibodies to toluene diisocyanate in an environmentally exposed population.

Authors:  K G Orloff; D Batts-Osborne; T Kilgus; S Metcalf; M Cooper
Journal:  Environ Health Perspect       Date:  1998-10       Impact factor: 9.031

9.  Longitudinal study of specific antibodies to toluene diisocyanate (TDI)-human serum albumin (HSA) conjugate in patients with TDI-induced asthma.

Authors:  Hae Sim Park; Soo Keol Lee; Young Mok Lee; Sun Sin Kim; Dong Ho Nahm
Journal:  Korean J Intern Med       Date:  2002-12       Impact factor: 2.884

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.